Park Ha Biological Tech-A
13F holders, Q2 2025 (June 30)13holders +9
10new positions
1sold out
1famous investor
$34.99avg. 13F price*
At the end of Q2 2025, 13 institutions reported holding Park Ha Biological Tech-A in their 13F filings, up 9 from Q1 2025. 10 opened new positions and 1 sold out. The largest holders were Citadel Advisors ($743K), Invesco Ltd. ($721K) and Geode Capital Management, LLC ($590K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Park Ha Biological Tech-A
- CUSIP
- G6925R102
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 10 | $2.7M |
| Exits | 1 | $195K |
All 13F filers, Q1 2025 → Q2 2025: 81,760 shares bought and 17,030 shares sold, net +64,730 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Citadel Advisors | 0.00% | Add +27.9% | 21,234 | $743K |
| Invesco Ltd. | 0.00% | New | 20,605 | $721K |
| Geode Capital Management, LLC | 0.00% | Add +0.4% | 16,854 | $590K |
| BNP Paribas Financial Markets | 0.00% | New | 12,030 | $421K |
| State of Wyoming | 0.05% | New | 12,016 | $420K |
| Scientech Research LLC | 0.07% | New | 8,352 | $292K |
| Morgan Stanley | 0.00% | New | 7,321 | $256K |
| Scotia Capital Inc. | 0.00% | New | 6,000 | $210K |
| Jane Street Group, LLC | 0.00% | New | 5,782 | $202K |
| Federation des caisses Desjardins du Quebec | 0.00% | New | 2,590 | $91K |
| UBS Group AG | 0.00% | New | 1,472 | $52K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 895 | $31K |
| Royal Bank of Canada | 0.00% | Reduce -99.2% | 19 | $1K |
"% of holder's portfolio" is PARK HA BIOLOGICAL TECH-A's weight in each manager's 13F, not the share of Park Ha Biological Tech-A the manager owns.